India is experiencing a significant change in healthcare towards personalized and precision medicine due to the advancements in molecular testing technologies. This change is leading to new possibilities in disease diagnosis, treatment selection, and patient care. With the biotechnology industry growing at a rate of
Dr Shivani Sharma, Vice-President of Pathology Services and Lab Director India is experiencing a significant change in healthcare towards personalized and precision medicine due to the advancements in molecular testing technologies. This change is leading to new possibilities in disease diagnosis, treatment selection, and patient care.
Recent data shows the number of people who beat cancer in India is set to go up by about 35% in the next ten years. With more people living after cancer, it's key to pay attention to their long-term health and how well they live.
CORE Diagnostics, a NABL accredited, Gurgaon-based high-end clinical laboratory, has recently received an accreditation certification from the College of American Pathologists (CAP), a leading international laboratory accrediting organization, based on the results of a recent assessment as part of the CAP’s Accreditation Programs. Accreditation by
